(19)
(11) EP 4 003 353 A1

(12)

(43) Date of publication:
01.06.2022 Bulletin 2022/22

(21) Application number: 20775397.1

(22) Date of filing: 22.07.2020
(51) International Patent Classification (IPC): 
A61K 31/48(2006.01)
A61P 27/02(2006.01)
 A61K 9/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/08; A61K 9/1075; A61K 9/19; A61K 31/48; A61K 47/10; A61K 47/12; A61P 27/02; A61K 9/0048
(86) International application number:
PCT/IB2020/056885
(87) International publication number:
WO 2021/014372 (28.01.2021 Gazette 2021/04)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 23.07.2019 PL 43067519

(71) Applicant: Oseka, Maciej
05-462 Duchnow (PL)

(72) Inventors:
  • SWIECH-ZUBILEWICZ, Anna
    20-572 Lublin (PL)
  • SALADZIAK, Katarzyna
    11-500 Gizycko (PL)
  • OSEKA, Maciej
    05-462 Duchnow (PL)

(74) Representative: JD&P Patent Attorneys Joanna Dargiewicz & Partners 
Ul. Mysliborska 93A/50
03-185 Warszawa
03-185 Warszawa (PL)

   


(54) BROMOCRIPTINE FOR USE IN TREATING EYE DISEASES ASSOCIATED WITH ELEVATED LEVEL OF VEGF AND A PHARMACEUTICAL COMPOSITION COMPRISING BROMOCRIPTINE